chartexchange

NITE
The Nightview Fund
stockNYSEETF

At CloseNov 18, 2026
35.57USD+0.666%(+0.24)3,679
After-hoursNov 18, 2026 4:10:30 PM EST
35.57USD-0.864%(-0.31)
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
HQ
Cincinnati, Ohio, USA
Previous Close
$35.33
Beta
1.38
52-Week High
$41.00 2026-09-03
52-Week Low
$32.52 2026-03-30
SMA 50
$38.26
SMA 200
$37.21
Avg. Vol 10D
9,704
Avg. Vol 30D
4,153
Avg. Vol 90D
3,092
Relative Vol
0.89
33.48M
5.1600%
3,529
Oct 29, 2026
Sep 29, 2026
Sep 23, 2026
NITE Profile

Nightstar Therapeutics Ltd is a clinical-stage gene therapy company. It is focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases.

NITE Performance
PeriodPriceDateChangeBeta
1W36.882026-11-12-3.68%1.445
1M38.342026-10-19-7.34%1.356
3M39.932026-08-19-11.02%1.486
6M37.132026-05-19-4.33%1.419
1Y34.402025-11-19+3.28%1.384
2Y29.022024-11-19+22.42%—
5Y25.412019-06-06+39.81%1.409
NITE Stock Summary

The Nightview Fund (NYSE:NITE) stock price today is $35.53, and today's volume is 3,679. NITE is up 0.539% today. The 30 day average volume is 4,153. NITE market cap is $1.19B with 33.48M shares outstanding.